Marc Cavan has joined Baker & McKenzie’s North American Intellectual Property Practice as a partner in Chicago, bringing more than 15 years of experience in life sciences IP litigation.
Mr. Cavan focuses his practice on patent litigation across a range of technologies. He has handled significant life sciences patent litigation involving cardiovascular stents, minimally invasive medical devices and surgical implants, as well as pharmaceuticals relating to anesthesia and the treatment of asthma and cancer. He also has experience litigating patent cases and intellectual property disputes involving electronic health records, mobile devices, web browser technology, nanotechnology, and software.
“Marc is an excellent addition to our strong capabilities in life sciences litigation in North America,” said Kevin O’Brien, Chair of the North American Intellectual Property Practice. “He has a tremendous amount of experience handling these complex matters for a range of clients in various industries, and I know our practice will benefit greatly from his unique expertise.”
Mr. Cavan has handled patent cases in federal district courts throughout the United States. His experience includes jury trials, abbreviated new drug application litigation, post-grant challenges before the Patent Trial and Appeal Board, and appeals before the Federal Circuit. He has also advised on intellectual property matters in significant life science mergers and acquisitions. Mr. Cavan is ranked as a leading patent litigator by Chambers USA and International Asset Management 1000: The World’s Leading Patent Practitioners.
“Chicago is home to an array of global pharmaceutical companies, and Marc has built an excellent reputation both in this market and throughout North America with his expertise in IP litigation matters,” said Michael Smith, Managing Partner of Baker & McKenzie’s Chicago office. “We are thrilled to have him join our team.”
Mr. Cavan joins one of the largest IP practices in the world, with more than 300 attorneys globally and 100 in North America. The Firm was named Global IP Law Firm of the Year 2015 by Managing IP Magazine, and has been ranked Band 1 for the last seven years by Chambers Global. In its 2015 WTR1000 rankings, World Trademark Review noted the Firm’s “unmatched international trademark practice” that makes it “a clear favorite for a multitude of multinationals.”
Baker & McKenzie regularly advises a range of pharmaceutical, medical device, biotech, and other healthcare companies across a variety of areas, including: M&A and corporate transactions; tax; compliance and regulation; antitrust; disputes, anticorruption, and intellectual property. Chambers Global 2015 took note of the Firm’s “extensive global network capable of handling all issues arising in the life sciences sector.”
“I’m very happy to join Baker & McKenzie,” said Mr. Cavan. “The Firm’s renowned global platform and truly integrated IP team will be a tremendous asset to my clients, and I look forward to working together with my new colleagues and further enhancing the level of service I can provide.”
Mr. Cavan is the latest in a series of prominent lateral hires to join the Firm in Chicago. In recent months, experienced corporate finance attorney Jai Khanna joined, as well as leading real estate attorney Michael Rechtin and employment litigator Arthur Rooney.
Mr. Cavan received his B.S. from Duke University, and his J.D. from Harvard Law School. He joins the Firm from Ropes & Gray LLP.
Source: www.bakermckenzie.com
